СПИСОК ИСПОЛЬЗОВАННЫХ ИСТОЧНИКОВ

Поставить закладку

БMЭ. Эрготизм. http://bigmeden.ru/article/%D0%AD%Dl%80%D0%BЗ%D0%BE%Dl%82%D0%B7%D0%BC. (27.12.2019. 13:40).
Волков В. П. Cepoтoнинoвый синдром (обзор литературы). Психиатрия и психофармакотерапия им. П. Б. Γaннyшкинa. 2012; 3: 37-45. Портал Consilium Medicum: httрs://con-med.ru/magazines/psikhiatriya_i_psikhofarmakoterapiya_im_psikhofarmakoterapiya_im_p_b_ganushkina-03-2012/serotoninovyy_sindrom_obzor_literatury/ (16.12.2019, 22:40)
Волков В. П. Ятpoгeнныe пcиxoнeйpocoмaтичecкиe синдромы. - Тверь: Триада, 2014. -320 с.
Любoв E. Б., Bacькoвa Л. Б., Tяпкинa M. В. Уровни суицидов и потребление антидепрессантов в России и её регионах // Cyицидoлoгия. Том 8, № 2 (27), 2017. – С. 49-53.
Attar-Herzberg D., Apel A., Gang Ν., Dvir D., Mayan Η. The serotonin syndrome: initial misdiagnosis. Isr Med Assoc J. 2009; 11(6):367-370.
Baigel G. D. Cyproheptadine and the treatment of an unconscious patient with the serotonin syndrome. Eur J Anaesthesiol. 2005;20:586-588.
Baldo B. A., & Rose, M. A. (2019). The anaesthetist, opioid analgesic drugs, and serotonin toxicity: a mechanistic and clinical review. British Journal of Anaesthesia. doi.l0.1016/j.bja.2019.08.010
Birmes P., Coppin D., Schmitt L., Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003;168(11):1439-1442.
Boyer E. W., Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112-1120.
Brensilver J. M., Smith L., Lyttle CS (September 1998). Impact of the Libby Zion case on graduate medical education in internal medicine. The Mount Sinai Journal of Medicine, New York. 65 (4): 296-300. PMID 9757752
Buckley N. A., Dawson A. H., Isbister G. K. Serotonin syndrome. BMJ. 2014;348:gl626.
Cameiro AMD, Cook E. H., Murphy D. L., Blakely R. D. Interactions between integrin alрhaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest. 2008;118:1544-1552.
Chander W. P., Singh Ν., Mukhiya G. К. Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression. J Indian Med Assoc. 2011;109:36-37.
Culbertson V. L., Rahman S. E., Bosen G. С, Caylor M. L., Echevarria M. M., Xu D. Implications of off-target serotoninergic drag activity: an analysis of serotonin syndrome reports using a systematic bioinformatics approach. Pharmacotherapy. 2018;38:888-898.
Dunkley E. J., Isbister G. K., Sibbritt D., Dawson A. H., Whyte I. M. The Hunter serotonin toxicity criteria: simple and accurate diagnostic decision rales for serotonin toxicity. QJM. 2003;96:635-42.
Eadie M. J. Convulsive ergotism: epidemics of the serotonin syndrome. Lancet Neurol. 2003;2:429-434.
Ener R. A., Meglathery S. B., van Decker WA et al. (2003). Serotonin syndrome and other serotonergic disorders.
Francescangeli J., Karamchandani K., Powell M., Bonavia A. The Serotonin Syndrome: From Molecular Mechanisms to Clinical Practice. Int J Mol Sci. 2019;20(9):2288. Published 2019 May 9. doi:10.3390/ijms20092288
Gillman P. K. Neuroleptic malignant syndrome: mechanisms, interactions, and causality. Mov Disord 2010;25(12):1780-90.
Gillman P. K. The serotonin syndrome and its treatment. J Psychopharmacol. 1999;13:100-109.
Goodman L. S., Branton, L. L., R. Hilal-Dandan, & Knollmann, В. C. (2018). Goodman & Gilman's pharmacological basis of therapeutics, 13th ed. McGraw-Hill.
Graudins A., Stearman A., Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med;16:615-619.
Hiraga A., Kuwabara S. Malignant Syndrome and Serotonin Syndrome in a General Hospital Setting: Clinical Features, Frequency and Prognosis. Intern Med. 2017;56(21):2865-2869. doi:10.2169/internalmedicine.8573-16
Hoffman Jan (January 1, 1995). "Doctors' Accounts Vary In Death of Libby Zion". The New York Times. Archived from the original on August 16, 2009. Retrieved 16.12.2019, 22:40. https://www.nytimes.com/1995/01/01/nyregion/doctors-accounts-vary-in-death-of-libby-zion.html
Horowitz B. Z., Mullins M. E. Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion. Pediatr Emerg Care. 1999;15:325-327.
Iqbal M. M., Basil M. J., Kaplan J., Iqbal M.T. Overview of serotonin syndrome. AnnClin Psychiatry. 2012;24:310-18.
Isbister G. К., Bowe S. J., Dawson Α., Whyte I. Μ. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004;42:277-285.
Isbister G. K., Buckley N. A. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol. 2005;28:205-214.
Katus L. E., Frucht S. J. Management of Serotonin Syndrome and Neuroleptic Malignant Syndrome. Curr Treat Options Neurol. 2016;18(9):39. doi:10.1007/s11940-016-0423-4
Lange-Asschenfeldt C., Weigmann H., Hiemke C., Mann K. Serotonin syndrome as a result of fluoxetine in a patient with tramadol abuse: plasma level-correlated symptomatology. J Clin Psychopharmacol. 2002;22:440-441.
Lee J., Franz L., Goforth H. W. Serotonin syndrome in a chronic-pain patient receiving concurrent methadone, ciprofloxacin, and venlafaxine. Psychosomatics. 2009;50:638-639.
Levin T.T., Cortes-Ladino A., Weiss M., Palomba M. L. Life-threatening serotonin toxicity due to a citalopram-fluconazole drug interaction: case reports and discussion. Gen Hosp Psychiatry. 2008;30:372-377.
Liu Y., Yang H., He F. et al. An atypical case of serotonin syndrome with normal dose of selective serotonin inhibitors: A case report. Medicine (Baltimore). 2019;98(19):e15554. doi:10.1097/MD.0000000000015554
Mackay F. J., Dunn N. R., Mann R. D. Antidepressants and the serotonin syndrome in general practice. Br J Gen Pract. 1999;49:871-874.
Martin Т. G. Serotonin syndrome. Ann Emerg Med. 1996;28:520-526.
Mason P. J., Morris V.A., Balcezak Т. J. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2000;79:201-209.
McDaniel W. W. Serotonin syndrome: early management with cyproheptadine. Ann Pharmacother. 2001;35:870-873.
Ott M., Mannchen J. K., Jamshidi F., Werneke U. Management of severe arterial hypertension associated with serotonin syndrome: a case report analysis based on systematic review techniques. Ther Adv Psychopharmacol. 2019;9:2045125318818814. Published 2019 Mar 11. doi:10.1177/2045125318818814
Racz R., Soldatos T. G., Jackson D., Burkhart K. Association between serotonin syndrome and second-generation antipsychotics via pharmacological target-adverse event analysis. Clin Transl Sci. 2018;11:322-329.
Saper СВ. Brainstem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, editors., eds. Principles in Neural Science. 4th ed. New York: McGraw-Hill; 2000:896.
Sauer W. H., Berlin J. A., Kimmel S. E. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation. 2003;108:32-36.
Scotton W. J, Hill L. J., Williams A. C, Barnes N. M. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. Int J Tryptophan Res. 2019 Sep 9;12:1178646919873925. doi: 10.1177/1178646919873925
Uddin M., Alweis R., Shah S. R. et al. Controversies in serotonin syndrome diagnosis and management: a review. J Clin Diagn Res. 2017;11 :OE05-OE07.UрToDate.com
Volpi-Abadie J., Kaye A. M., Kaye A. D. Serotonin syndrome. Ochsner J.2013;13:533-540.
Werneke U., Jamshidi F., Taylor D. M., Ott M. Conundrums in neurology: diagnosing serotonin syndrome - a meta-analysis of cases. BMCNeurol. 2016;16:97.